Targeting BCL-XL in fibrolamellar hepatocellular carcinoma.
Shebl B, Ng D, Lalazar G, Rosemore C, Finkelstein TM, Migler RD, Zheng G, Zhang P, Jiang CS, Qureshi A, Vaughan R, Yarchoan M, de Jong YP, Rice CM, Coffino P, Ortiz MV, Zhou D, Simon SM.
Shebl B, et al. Among authors: jiang cs.
JCI Insight. 2022 Sep 8;7(17):e161820. doi: 10.1172/jci.insight.161820.
JCI Insight. 2022.
PMID: 36073545
Free PMC article.